自然杀伤细胞
淋巴因子激活杀伤细胞
自然杀伤性T细胞
白细胞介素12
细胞因子诱导的杀伤细胞
白细胞介素21
NK-92
细胞毒性T细胞
NKG2D公司
白细胞介素15
免疫系统
癌症研究
细胞毒性
Janus激酶3
化学
细胞生物学
作者
Idoia Mikelez-Alonso,Susana Magadán,África González-Fernández,Francisco Borrego
标识
DOI:10.1016/j.addr.2021.113860
摘要
Natural killer (NK) cells are lymphocytes able to exert potent antitumor and antiviral functions by different means. Besides their classification as innate lymphoid cells (ILCs), NK cells exhibit memory-like and memory responses after cytokine preactivation, viral infections and hapten exposure. Multiple NK cell-based immunotherapies have been developed and are currently being tested, including the possibility to translate the NK cell memory responses into the clinic. Nevertheless, still there is a need to improve these therapies, especially for the treatment of solid tumors, and nanotechnology represents an attractive option to increase NK cell effector functions against transformed cells. In this article, we review the basis of NK cell activity, the diversity of the NK cell memory responses and the current NK cell-based immunotherapies that are being used in the clinic. Furthermore, we take a look into nanotechnology-based strategies targeting NK cells to modulate their responses for effective immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI